Peter has over 25 years of experience in research & development, drug development & commercialization, licensing, business & corporate development as well as general management. He has been directly involved in start-up ventures, publicly-held entities, strategic transactions, improving shareholder value, and mergers and acquisitions. Peter is a co-founder of Sinfonie LSM GmbH and a co-founder and previous CEO of MediGene AG and of MagForce AG. He has an educational background in biology and chemistry and received a PhD in biochemistry. After that he was a post-doc scientist for two years at Harvard University. Peter is a co-founder of BIO Deutschland, Germany´s Biotech industry organization and has been its Chairman from 2004-2020. He also serves on the Board of EuropaBio, the European Association for Bioindustries, which is Europe's largest and most influential biotech industry group. He was a previous member of the Board of the European Emerging Biopharmaceutical Enterprises (EBE), serving from 2003 – 2006 as EBE’s President. From 2014-2020 he served as a Member of the Scientific Panel for Health (SPH) of the European Commission for Horizon 2020. From 2016-2020 he was also member of the board of the Federation of German Industries (BDI), the voice of the German industry. Peter is a serial entrepreneur (MediGene, MediGenomix, Immunocor, Adaptimmune, Syntab) and acts as Board member of some Biotech companies.